Literature DB >> 11128762

The effects of hyperglycemia on skin graft survival in the burn patient.

A Mowlavi1, K Andrews, S Milner, D N Herndon, J P Heggers.   

Abstract

The authors elected to determine the relative effects of hyperglycemia and/or elevated wound Gram-positive bacterial counts on success of skin graft survival in 74 burn patients. Results of serum glucose and quantitative wound biopsies on the day of admission and on postoperative day 4 were charted. Cases were separated into the following groups for analysis: normoglycemia plus normal bacterial counts, elevated bacterial counts only, hyperglycemia only, and hyperglycemia plus elevated bacterial counts. Successful graft "take" was defined as survival of 80% to 100% of the grafted area as assessed on postoperative day 4. Significant results included decreased incidence of graft take for groups with hyperglycemia only (62.5%), elevated bacterial counts only (63.3%), as well as hyperglycemia plus elevated bacterial counts (54.5%) when compared with the group with normoglycemia plus normal bacterial counts (92.8%; p = 0.020, p = 0.042, p = 0.012 respectively) for physiological parameters measured on postoperative day 4 only. Additionally, incidence of graft take was reassessed and found to be decreased significantly in groups with hyperglycemia (60.0%) vs. groups with normoglycemia (84.6%), regardless of Gram-positive bacterial counts (p = 0.034).

Entities:  

Mesh:

Year:  2000        PMID: 11128762     DOI: 10.1097/00000637-200045060-00010

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  24 in total

1.  Novel cryoprecipitate for wound healing and skin grafts in rats.

Authors:  Thomas Scholz; Joshua Waltzman; Garrett A Wirth; Senait W Dyson; William J Owens; Edward Shanbrom; Gregory R D Evans
Journal:  Int Wound J       Date:  2008-10       Impact factor: 3.315

Review 2.  Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement.

Authors:  Elizabeth A Mann; Alejandra G Mora; Heather F Pidcoke; Steven E Wolf; Charles E Wade
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3. 

Authors:  F Ravat; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-12-31

Review 4.  Diabetes mellitus and burns. Part II-outcomes from burn injuries and future directions.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

5.  Sepsis Increases Muscle Proteolysis in Severely Burned Adults, but Does not Impact Whole-Body Lipid or Carbohydrate Kinetics.

Authors:  Andrew Murton; Fredrick J Bohanon; John O Ogunbileje; Karel D Capek; Ellen A Tran; Tony Chao; Labros S Sidossis; Craig Porter; David N Herndon
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

6.  Predicting acute kidney injury among burn patients in the 21st century: a classification and regression tree analysis.

Authors:  David F Schneider; Adrian Dobrowolsky; Irshad A Shakir; James M Sinacore; Michael J Mosier; Richard L Gamelli
Journal:  J Burn Care Res       Date:  2012 Mar-Apr       Impact factor: 1.845

7.  Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients.

Authors:  Janett Kreutziger; Volker Wenzel; Andrea Kurz; Mihai Adrian Constantinescu
Journal:  Intensive Care Med       Date:  2009-02-24       Impact factor: 17.440

Review 8.  Metabolic implications of severe burn injuries and their management: a systematic review of the literature.

Authors:  Bishara S Atiyeh; S William A Gunn; Saad A Dibo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 9.  Inpatient diabetology. The new frontier.

Authors:  Nicolas N Abourizk; Chaula K Vora; Parveen K Verma
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

10.  Burns in diabetic patients.

Authors:  Hemmat Maghsoudi; Naser Aghamohammadzadeh; Nasim Khalili
Journal:  Int J Diabetes Dev Ctries       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.